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ABSTRACT
The Coronavirus Infectious Disease 2019 (COVID-19) pandemic has affected most nations at all levels of
functioning, individual to governmental. Therefore, it is imperative to evaluate the effects the virus has had on one
of the most important socioeconomic global sectors – healthcare. This comprehensive literature review explores
key, recent research and management strategies that have been undertaken in healthcare systems around the world
in order to make meaningful attempts at identifying the etiology, diagnosis, and treatment the disease, and
combating the spread of this deadly virus. Healthcare facilities have implemented a variety of changes, all geared
towards reducing non-emergency patient visits and preventing transmission of the infection; this includes shifting
appointments to online modality via telecommunication use, altering remedial options and procedures, and
developing more effective personal protective equipment (PPE). Efforts have also been made to define appropriate
treatment methods as well as a potential cure for COVID-19; many vaccines and antiviral drugs are being designed
or undergoing clinical testing, and symptom management approaches are being employed along with careful
evaluation or recommendation of already available medications to counter the disease.

Keywords: COVID-19 pandemic, global effects, healthcare research and management.
1 Introduction
On March 11, 2020, the World Health Organization (WHO) declared the Coronavirus Infectious Disease 2019
(COVID-19) to be a pandemic, affecting multiple countries worldwide, and infecting millions of individuals
(Cucinotta & Vanelli, 2020). The novel strain of this family of viruses, Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), originated in late 2019 within Wuhan, China, with a spread that rapidly
developed and disproportionately infected those over 40 years of age (Rabi et al., 2020). Individuals with
comorbid conditions, such as cancer and cardiovascular disease, are especially at risk of infection and have an
increased chance of mortality due to a weakened immune system (Cinar et al., 2020; Shaheen et al., 2020;
Weinkove et al., 2020). The origin of this coronavirus is still relatively unknown; however, there has been
speculation that it may have originated from the preparation of bats in a seafood market of Wuhan, China, or
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the manipulation of another coronavirus within a laboratory (Rabi et al., 2020). Nonetheless, recent studies
have isolated SARS-CoV-2 as the main strain causing the disease, containing an angiotensin-converting enzyme2 (ACE-2) binding domain, which binds the ACE-2 receptor in various vital organs throughout the body (Rabi
et al., 2020). The wide disbursement of the ACE-2 receptor within the human body may cause infection of
COVID-19 to provide a wide variety of symptoms in some patients, making the illness even more complex to
treat and manage. The predominant means of transmission of the coronavirus is production of respiratory
droplets, which may land on nearby surfaces or travel through the air and be inhaled by another individual
(Rabi et al., 2020). The incubation period of this virus is relatively long, spanning anywhere between 2-14 days
prior to symptom development; thus, an individual may be unknowingly infected and could pass on the virus
to others quite easily (Rabi et al., 2020).
The recent COVID-19 outbreak has impacted various areas of research and management of healthcare
throughout the globe. Federal and state governments of numerous countries have ordered frequent lockdowns,
forcing the workforce to move operations online, and instilling new terms, such as “social distancing” to assist
in controlling the contagion. In the realm of healthcare, new research methodologies and management practices
have been quickly underway to develop effective treatment options and a possible cure for COVID-19.
Preventative protocols have been put in place within healthcare facilities to inhibit the spread of the virus and
lessen the risk of transmission among people or communities. The occurrence of COVID-19 has transformed
many fields of medicine and continues to manifest before the eyes of the world. The disease is new and largely
unknown, with perspectives constantly evolving due to repeated mutations of the virus, rendering it one of the
most influential topics of worldwide concern in recent times. The goal of this literature review is to highlight
recently published, notable reports on the effects of COVID-19 on multifarious aspects of healthcare research
and management across the world.
2 Effects of COVID-19 on Healthcare Research and Management
2.1 Patient Care Management
COVID-19 has posed significant risks to healthcare workers and patients in the healthcare setting, especially
those who are immunocompromised or require urgent care. This has caused healthcare facilities around the
world to make significant changes in ways of providing healthcare efficiently and effectively. Among the initial
changes made by healthcare systems following the pandemic’s onset was the cancellation of elective surgeries
and the implementation of telecommunication for physician appointments (Hojaij et al., 2020; Lindeman et al.,
2020). Such processes have been applied in healthcare facilities across Norway, Sweden, the United States,
Australia, England, and Egypt. These efforts allow for the reduction in volume of patients within the hospital,
reducing possible transmission of the virus, while permitting vital resources to be allocated to patients who are
severely ill, whether suffering from COVID-19 or other ailments (Lindeman et al., 2020). Remote monitoring
of patient conditions is now being widely utilized; in England, for example, a smartphone app (TeleCheck-AF)
is being applied on cardiac patients who may experience atrial fibrillation (Klompstra & Jaarsma, 2020). The
application uses smartphone technology to check the patient’s pulse and evaluate any changes for signs of atrial
fibrillation; this information is consistently synced with physician charts for examination, enabling continuous
remote monitoring of the patient’s health (Klompstra & Jaarsma, 2020). Cardiac patients in England now also
have the opportunity to complete rehabilitation programs from home; projects such as “Activate Your Heart”,
AIJR Preprints
Available online at preprints.aijr.org

Page 3 of 11
Stephanie Autore & Santanu De, AIJR Preprints, 314, version 1, 2021

which offer home exercise programs for cardiac patients, are now being offered on video-chat software and
have even seen an increase in usage by patients since the start of the pandemic (Klompstra & Jaarsma, 2020).
For individuals who must receive in-patient care due to a severe condition, hospitals and other healthcare
facilities have been enforcing strict guidelines within the system to hinder distribution of the virus. Such
regulations include the mandate of wearing facial coverings within the hospital setting, restricting or reducing
visitors from entering clinics, and testing for COVID-19 prior to surgery and other procedures (Shaheen et al.,
2020; Weinkove et al., 2020). Some immunocompromised patients who are receiving ongoing treatment, such
as chemotherapy for cancer, may have their treatment schedules altered to mitigate the need for in-person visits;
however, this depends on the stage and rate of growth of the condition (Cinar et al., 2020; Weinkove et al.,
2020). Egypt has also taken steps to establish separate hospitals focused on treating COVID-19 patients only;
this would assist in preventing cross-contamination between hospital departments (Hoe Gan et al., 2020;
Shaheen et al., 2020). Patients are placed in the COVID-19 hospital after being tested for the virus through
COVID-19 screening procedures; if a patient tests positive for COVID-19, he or she must immediately be
transferred to the designated COVID-19 hospital for treatment, while a negative result would allow the patient
to be placed in a temporary holding ward until retesting and further placement into the appropriate department
are carried out (Shaheen et al., 2020).
Social-distancing measures have been established within hospital waiting rooms; seats are now placed six
feet apart from one another on all sides (Shaheen et al., 2020). Singapore has also taken a special initiative into
consideration to develop strategies that limit the spread of the virus in the healthcare setting: the Systems
Engineering Initiative for Patient Safety (SEIPS), which provides a holistic view of healthcare – visualizing how
each healthcare worker interacts with the environment and associated technologies (Hoe Gan et al., 2020). With
recommendations from SEIPS, Singapore has implemented body temperature checks twice daily for healthcare
workers, with the temperature not to exceed 37.5℃ (Hoe Gan et al., 2020). Additionally, the use of negative
pressure patient-care rooms has been established to prevent air contamination between rooms and other
facilities (Hoe Gan et al., 2020).
Many healthcare services have been modifying the way certain medical procedures are performed to prevent
aerosolization of respiratory particles; procedures that increase the risk of aerosolization include intubation,
extubation, and manual ventilation procedures (Herron et al., 2020). However, in some nations, such as the
United Kingdom, these procedures may not be recognized as providing an increased risk of transmission, likely
increasing the chances of spread of the virus to others (Herron et al., 2020). In oncology departments within
the United States, procedures that screen for cancer are being modified from endoscopies and bronchoscopies
to Computed Tomography (CT)-guided biopsies to reduce the production of respiratory droplets (Cinar et al.,
2020). If high-risk aerosolization procedures cannot be avoided, then stringent precautions are taken; for
example, in the cardiology departments within Egypt, intubation procedures are completed prior to entrance
into the operating room, ensuring that all nonessential personnel exit the room first (Shaheen et al., 2020). With
these efforts, the hospital departments are ensuring that COVID-19 is under control within the realm of
healthcare as much as possible.
2.2 Personal Protective Equipment (PPE)
The high transmissibility of COVID-19 has caused a rapid increase in the need for the manufacture and use of
appropriate personal protective equipment (PPE) to protect healthcare workers. COVID-19 spreads primarily
AIJR Preprints
Available online at preprints.aijr.org

Page 4 of 11
Effects of COVID-19 on Global Healthcare Research and Management

through respiratory droplets, which can travel through the air or land on surfaces prior to being consumed or
inhaled by another individual (Rabi et al., 2020). The length of time that the virus may survive on a surface
depends on the material, whether porous or solid; however, this range can vary between a few hours to several
days (Rabi et al., 2020; Wesemann et al., 2020). Research conducted in the United Kingdom has recognized
aerosolized droplets as carrying a significant viral load and posing the highest risk to healthcare staff (Herron
et al., 2020). Thus, studies have been conducted all over the world to develop proper PPE that will protect the
health of frontline workers during this unprecedented time. Such PPE includes the use of face-masks, goggles,
face-shields, gloves, and gowns, with a study conducted in Switzerland determining that the most effective
coverage is offered by a combined use of all of these forms of PPE (Haleem et al., 2020; Herron et al., 2020;
Wesemann et al., 2020). There are more stringent guidelines as to what forms of PPE offer the most protection:
masks must be either N-95 or FFP2 grade material to block the small size of viral particles (70-90 nm) that
standard surgical masks are ineffective at blocking; masks must also be well-fitted, ensuring complete coverage
around the nose and mouth (Herron et al., 2020). Furthermore, face-shields must extend below the chin and
to the ears, while also allowing space for goggles and a mask to be worn underneath (Wesemann et al., 2020).
Among the primary concerns regarding the use of PPE is that healthcare workers have been experiencing
a shortage of protective equipment, as well as a possible lack of adequate training regarding its use; this poses
a significant risk to the health and lives of frontline workers (Herron et al., 2020; Wesemann et al., 2020). Some
recommendations, such as the manufacture of face-shields and other forms of PPE within the hospital, have
been made to increase the availability and distribution of PPE to healthcare workers (Wesemann et al., 2020).
A perspective of the SEIPS model developed in Singapore also suggests that the PPE worn be selected based
on the viral load and risk of infection of certain procedures, as this would slow the depletion of supplies (Hoe
Gan et al., 2020). A study in the United Kingdom proposes that a supervisor or “buddy-system” be utilized
when dressing in PPE to ensure proper placement and use (Herron et al., 2020). In developing countries as
well, such as Africa, a shortage of PPE has been noticed; increases in manufacture of these materials and other
vital medical equipment has been progressing (Ihekweazu & Agogo, 2020). Due to the rough terrain and
difficult-to-reach locations of some medical clinics and hospitals in Africa, there has been an operation of
utilizing drones to transport material quickly and efficiently, greatly reducing the transport time of imperative
medical supplies (Ihekweazu & Agogo, 2020). Without the use of PPE, the spread of the coronavirus would
increase exponentially and put the lives of populations in potential danger, making the virus even more difficult
to control.
2.3 Treatment Options
The symptoms of COVID-19 can be discomforting and debilitating, with the most common consisting of dry
cough, fever, and shortness of breath, which may manifest into pneumonia and develop further complications
that may lead to death (National Institute for et al., 2020; Rabi et al., 2020). Furthermore, the symptoms
experienced by children can be different than those experienced by adults and tends to take the form of another
ailment: Pediatric Multisystem Inflammatory Syndrome, characterized by fever, cough, edema, and decreased
heart functioning (Deza Leon et al., 2020). Due to the virus’s novelty, currently there is no vaccine or medication
available that cures the illness; however, several clinical trials are being conducted on individuals who suffer
from COVID-19. England has made many attempts to establish a proper treatment option for COVID-19;
among these is the use of medications already on the market, such as Chloroquine and Hydroxychloroquine
AIJR Preprints
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(Mahase, 2020; Mendes, 2020). Chloroquine and Hydroxychloroquine have been utilized to treat a variety of
conditions, such as malaria, arthritis, SARS, and MERS; they function by conducting a neutralization reaction
that will deactivate acids (Mahase, 2020; Mendes, 2020). If a cell is equipped with
chloroquine/hydroxychloroquine and becomes invaded by a virus, it will be able to neutralize the acidic
environment required for the virus to survive (Mahase, 2020). Studies in England have also found Remdesivir
to be a promising remedial approach against COVID-19, as it functions to inhibit the replication processes of
viruses (Mahase, 2020; Mendes, 2020).
One of the most recent treatment methods being explored in Europe is the use of convalescent plasma,
which is obtained from an individual who survived a virus and contains antibodies for fighting against the viral
particles (Brown & McCullough, 2020). Convalescent plasma is normally utilized during epidemic situations, in
which there is a lack of vaccination or effective cure for an illness, as seen during the Spanish influenza of 19181920 (Brown & McCullough, 2020). Studies administered in England and Wuhan, China have found that when
administered to an individual with COVID-19, convalescent plasma works best in the early stages of viral
infection, as the antibodies IgG and IgM are at their highest levels (Brown & McCullough, 2020; Ye et al.,
2020). Convalescent plasma also does not have any known adverse side-effects and allows for protection of
further infection for up to a few months after injection (Brown & McCullough, 2020; Ye et al., 2020). Besides,
clinical trials conducted in China have found that the use of convalescent plasma also assists in the functioning
of the cardiovascular and immune systems, providing increased oxygenation to tissues, and decreases
inflammation and viral load, with a lesser risk of being admitted to the Intensive Care Unit (Brown &
McCullough, 2020; Ye et al., 2020). While convalescent plasma has been quite effective in treating COVID-19,
there has been an issue that is difficult to overcome: the supply of convalescent plasma to is too low to assist
in treating every individual who is infected; this is because far more individuals are ill with the coronavirus than
those who have fully recovered (Brown & McCullough, 2020). It is also imperative to ensure that the
convalescent plasma is devoid of any other pathogens and impurities; the process of filtering plasma mirrors
the screening process of blood transfusions: all contaminations must be removed via the use of Pathogen
Reduction Technology (PRT) (Brown & McCullough, 2020). Countries such as Australia and New Zealand,
however, do not have access to such technologies, rendering the need for stringent donor guidelines (Weinkove
et al., 2020).
Vaccination trials have also been underway in many countries, with a few currently conducting animal trials
for effectiveness and one study being expedited towards human trials (Mendes, 2020). The adenovirus vaccine
is currently in the second phase of development, with others trailing close behind in phase I; these include the
application of an inactivated form of the coronavirus and the use of plasmid DNA to fight the virus prior to
infection (Lv et al., 2020). While the development of an effective vaccine seems promising, the release may take
at least one year (Mendes, 2020); thus, healthcare workers must continue to utilize symptom management
techniques to care for patients.
2.4 Management of COVID-19 Symptoms
According to the National Institute for Health and Care Excellence (NICE), treatment of the common
symptoms of COVID-19 depends on the severity of the condition; for example, a light cough and sore throat
may be alleviated with honey, while a more powerful cough may render the need of a codeine medication
(National Institute for et al., 2020). The administration of paracetamol has been found to be most effective in
AIJR Preprints
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reducing fevers of those who are ill with COVID-19 (National Institute for et al., 2020). In order to manage
shortness of breath, certain breathing techniques have been effective, such as “pursed-lip breathing” as well as
medications like antiemetics (National Institute for et al., 2020). Furthermore, ventilators may be required if the
patient has severe difficulty breathing on their own; however, there have been shortages of ventilators in major
hospitals due to the large influx of COVID-19 patients (Torres et al., 2020). Thus, hospitals in Brazil have been
proposing the use of anesthesia machines to substitute the use of ventilators whenever necessary (Torres et al.,
2020).
COVID-19 can also take a psychological toll, increasing levels of anxiety and stress among the patient,
family, and healthcare professionals (National Institute for et al., 2020; Tsamakis et al., 2020). In a study
conducted in China, there were higher incidences of stress and anxiety by healthcare workers due to the
COVID-19 pandemic, with nurses experiencing worse symptoms than physicians; this also coincides with the
experiences of hospitals in Greece (Tsamakis et al., 2020). The stress experienced by the individual may also
manifest into physical discomfort viz; difficulty in breathing, hypoxia, and constipation (National Institute for
et al., 2020). Among the most common corrective actions for anxiety and stress during the pandemic is
communication; patients, families, and healthcare workers must address any concerns regarding prognosis and
treatment (National Institute for et al., 2020; Tsamakis et al., 2020). The administration of anti-anxiety
medications, such as benzodiazepine may also be helpful in easing anxiety (National Institute for et al., 2020).
Adjusting to the new way of life the pandemic has brought along is challenging and may take some time to
become accustomed to; however, through interpersonal interactions regarding the virus and coping measures,
people may be able to remain calm and make appropriate decisions regarding their health safety and
management.
3 Discussion
COVID-19 has led to remarkable reforms in healthcare research and management at multiple levels worldwide.
In the United States and other countries around the world, most non-essential healthcare activities were
cancelled or postponed, and governments had to declare a shut-down of in-person related economic activities
in attempts to curb the spread of the virus. Several medical facilities have moved their functions online via
remote services, such as Zoom meetings on Zoom, Skype, or other digital platforms. Students, faculty, and
college administrators had already been facing a multitude of barriers in STEM education, given its changing
landscape in recent times (Arguello et al., 2020; De & Arguello, 2020). In this context, COVID-19 impacted
not only healthcare research and management but education in healthcare and STEM, among most other
academic sectors (Autore et al., 2020; Autore et al., 2021; De, 2020b; Hallett et al., 2021; Hallett & De, 2020;
Hoang et al., 2021).
Though absence of in-person interactions have made people face inconveniences often during these
unusual circumstances, conscious efforts to inhibit the transmission of the virus must continue to be exercised
by everyone to ensure health and wellness of themselves and others. These can be achieved by increased
exposure to knowledge about the virus: how it functions or spreads, and how surfaces can be properly
disinfected; in other words, the population must increase their health literacy (Paakkari & Okan, 2020). Health
literacy involves gathering accurate information in order to apply it to make judicious, informed decisions
regarding one’s health (Paakkari & Okan, 2020). Administrative authorities of many countries have been taking
steps to promote health literacy; however, those would not be successful without active cooperation of the
AIJR Preprints
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general population to educate themselves and their families and children about the importance of proper
hygiene, cleanliness, and regular sanitary habits. Given the COVID-19-based global socioeconomic crisis,
knowledge of food safety and scientific research undertaken to meet the rising demands of food and nutrition,
especially in developing countries, need to be acquired and disseminated (De, 2010; De, 2019, 2020c; De &
Bandyopadhyay, 2008).
Greater efficiency of research and management among healthcare professionals is not possible without
improving healthcare/science education in schools and colleges. In order to meet the aggravated COVID-19based demands of e-pedagogy, educators and academic administrators may consider relevant instances of
empowering the youth with awareness and interest in science through modern online tools such as costeffective mobile applications with real-world relevance at middle/high school or college levels (De & Nethi,
2019; De & Nethi, 2020; Nethi & De, 2019; Nethi & De, 2020), fostering engagement and learning among
healthcare science students by developing and implementing virtual classrooms (De & Cavanaugh, 2020),
organizing and supporting digital leadership forums (De, 2020a), employing new means of course assessment
such as peer-video-blogs (Luyegu & De, 2020), and may need to restructure novel assessment strategies recently
designed for research-based science courses (Kapil, De, et al., 2021; Kapil, Pathak, et al., 2021; Kim, Haughton,
et al., 2020; Kim, Muchintala, et al., 2020; Pathak et al., 2021).
On the other hand, COVID-19 has caused heightened health safety concerns and stress among people, so
much so, that individuals are worried to even enter a healthcare facility. Due to this, many hematology
departments are experiencing lower yields of blood samples donated or available for transfusions (Barrett, 2020;
Cinar et al., 2020). On account of this shortage, hospitals in Africa have been implementing Patient Blood
Management (PBM) techniques to decrease the need for blood transfusions whenever possible, which consist
of increasing erythropoiesis and reducing the risk of blood loss (Barrett, 2020). Hematology departments in
Australia are addressing this issue through administration of supplements that enhance the functioning of
erythrocytes, such as iron, vitamin B12, and folic acid (Weinkove et al., 2020). There is hope that, with such
continued endeavors, complemented by fostering health literacy among the masses, the pandemic will be
brought under control and the health of global populations will flourish again.
4 Conclusions
The impact that the COVID-19 pandemic has had on healthcare research and management have been intense
and alarming. Healthcare professionals have been applying their knowledge of pre-existing diseases and viruses
to their immediate practice in the field of medicine, including major shifts to telecommunication in multiple
relevant domains, and altering treatment protocols to inhibit transmission of the infection through respiratory
droplets. Significant efforts have been made to protect essential or frontline healthcare workers, patients, and
the surrounding population with the use of PPE, while assessing the risk of contamination with appropriate
combinations of protective wear. COVID-19 has not only influenced individuals physically, but also socially,
economically, emotionally, and psychologically, necessitating timely and widespread communication of
healthcare research/management updates to help people avoid stress and uncertainty during the pandemic, and
to provide the population and healthcare workers with accurate information concerning the virus. While the
novel coronavirus presents ambiguities regarding proper remedial measures to prevent the infection, control
the symptoms, and cure the disease, various clinical research investigations are being performed throughout
the world to determine the quickest and most effective form of care, with minimal side-effects. Furthermore,
AIJR Preprints
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the history of earlier pandemics may provide some optimism that the spread of the coronavirus will eventually
be under control and the case-curves will flatten upon successful production of vaccines through validated
human clinical trials coupled with generation of herd immunity in populations, improved antiviral medications,
and cutting-edge treatment procedures. This paper encapsulates recently published scientific literature citing
critical developments in healthcare research and management practices in response to COVID-19. Numerous
fresh endeavors are continuing across the world including faster and more accurate diagnostic strategies to
detect the infection, design of vaccines and better antiviral drugs for prevention and potential cure, to name a
few. Therefore, a possible limitation of the present literature review could be its inability to provide an
exhaustive list of all relevant reports on the impact of COVID-19 on global health research and management.
Nonetheless, the study could serve as a foundation for pertinent future projects; for instance, improvements
aimed at ensuring cost-effective, personalized healthcare among underprivileged and minority populations and
people from socioeconomically challenged backgrounds or difficult geographical locations in developing
countries, on a case-by-case basis. Moreover, additional healthcare management and research on COVID-19associated illnesses and the impact on pediatric patients is necessary for a cohesive understanding of the novel
coronavirus and its implications in patients of specific age-groups.
5 Declarations
5.1 Study Limitations and Future Recommendations
Owing to the ongoing status of the pandemic, new studies from various countries are continuing to be
published on the topic. Hence, this literature review is not exhaustive of all possible COVID-19-related
implementations of health research and management practices yet accomplished around the world.
Recommended further research could focus on age-appropriate clinical interventions, with possible emphasis
on minorities or underprivileged communities in developing countries, while also taking into consideration
better treatment strategies and healthcare policy solutions regarding conditions associated with COVID-19; for
example, Pediatric Multisystem Inflammatory Syndrome.
5.2 Competing Interests
The authors declare that there were no conflicts of interest involved in this literature review.
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